Let's Find Opportunities Overseas
Tag: insider buying
👟 On Holding (ONON): Founders Just Bought the Dip — Is the Next Leg Up Starting?
On Holding (ONON) isn’t just selling running shoes anymore — it’s building a premium global sportswear empire with luxury-level margins, explosive APAC growth, and founders aggressively buying the dip. After falling 42% from its highs, ONON may now offer one of the most compelling GARP setups in consumer growth.
🚛 Waste Connections (WCN): Trading Trash for Pure Cash
Waste Connections (WCN) may operate in garbage, but its business model is pure gold. After a 23% pullback from all-time highs, founder-CEO Ronald Mittelstaedt just bought $7.6 million worth of shares in the open market. With elite margins, recession-resistant cash flow, institutional dominance, and almost zero short sellers, WCN looks less like a trash company and more like a compounding machine disguised as a dump truck.
🇧🇷 PAGS Stock: $5M Insider Bet—Hidden Gem or Value Trap? 🏦
A profitable fintech trading at a deep discount, backed by insider buying and short squeeze potential. PAGS could be one of 2026’s most overlooked plays.
Why Sensata’s CEO Is Buying This Overlooked Sensor Stock
Insiders Keep Buying Amcor: Do Those Encores Signal the Stock’s a Nice Package?
Amcor insiders are piling in, the dividend yields over 6%, and valuation looks cheap. Is AMCR a boring box… or a beautiful opportunity?
Tilray Brands But No Sunshine: Can Shareholders Finally Fly High?
Tilray’s stock is flying higher… again. But after years of false starts, net losses, and wild dreams, is this the real lift-off—or just another high followed by a low? Find out what’s cooking with Tilray’s drinks, cannabis brands, AI strategy, and why its reverse stock split is both approved and… on pause.
Crispr Therapeutics AG (CRSP) Insider Buys Big — Should You?
🚨 CRISPR Therapeutics just got two massive insider injections — and not the lab kind. Add in CASGEVY® expansion, gene therapy milestones, and a $1.7B cash pile, and you might want to splice this one into your portfolio.
Insider Buy, Buffett Stamp, Swiss Roots: Is Chubb the Coolest Name in Insurance?
Wildfires can’t scorch this Swiss insurance juggernaut. With Buffett, big buys, and billion-dollar buybacks, Chubb may be the steadiest hot stock around. 🧯📈
Coupang (CPNG): Another $37 Million Says... This E-Commerce Giant Isn’t Done Yet
Insiders and hedge funds are piling into Coupang (CPNG)—the Amazon of South Korea—but is it a smart buy or just an expensive gamble? With soaring revenue, strong growth in Eats, Play, and Fintech, and no debt, the company looks solid. But with thin margins, political unrest, and a sky-high P/E of 290, is the stock's future as promising as it seems? 🤔🚀
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
